Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel […]
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
Southside Bancshares, Inc. Increases and Declares Cash Dividend
TYLER, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Southside Bancshares, Inc., (NASDAQ:SBSI), parent company of […]
Glacier Bancorp Completes Acquisition of Community Financial Group, Inc. in Spokane, Washington
KALISPELL, Mont., Feb. 01, 2024 (GLOBE NEWSWIRE) — Glacier Bancorp, Inc. (“Glacier”) (NYSE: GBCI), today announced the completion of its […]
Gray and Marquee Broadcasting Swap Television Station Assets
ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray” or the “Company”) (NYSE: GTN) announced today that it […]
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and […]
Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present […]
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
STAMFORD, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic […]
Stem Holdings, Inc. Announces Effectiveness of Reverse Stock Split on February 1, 2024.
BOCA RATON, FL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (the “Company” or “Stem”) (OTC Pink: STMH CSE: […]
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical […]
